Spyre Therapeutics Statistics

Total Valuation

SYRE has a market cap or net worth of $5.92 billion. The enterprise value is $5.23 billion.

Market Cap	5.92B
Enterprise Value	5.23B

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

SYRE has 86.26 million shares outstanding. The number of shares has increased by 36.21% in one year.

Current Share Class	86.26M
Shares Outstanding	86.26M
Shares Change (YoY)	+36.21%
Shares Change (QoQ)	+24.29%
Owned by Insiders (%)	6.05%
Owned by Institutions (%)	90.63%
Float	75.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	10.05
P/TBV Ratio	10.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.25

Current Ratio	13.25
Quick Ratio	12.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.17% and return on invested capital (ROIC) is -22.26%.

Return on Equity (ROE)	-25.17%
Return on Assets (ROA)	-19.80%
Return on Invested Capital (ROIC)	-22.26%
Return on Capital Employed (ROCE)	-30.53%
Weighted Average Cost of Capital (WACC)	20.43%
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	102
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-15,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +385.70% in the last 52 weeks. The beta is 2.94, so SYRE's price volatility has been higher than the market average.

Beta (5Y)	2.94
52-Week Price Change	+385.70%
50-Day Moving Average	50.08
200-Day Moving Average	30.39
Relative Strength Index (RSI)	65.61
Average Volume (20 Days)	1,363,323

Short Selling Information

The latest short interest is 11.67 million, so 13.53% of the outstanding shares have been sold short.

Short Interest	11.67M
Short Previous Month	10.44M
Short % of Shares Out	13.53%
Short % of Float	15.36%
Short Ratio (days to cover)	9.41

Income Statement

Revenue	n/a
Gross Profit	-171.65M
Operating Income	-219.56M
Pretax Income	-155.22M
Net Income	-126.54M
EBITDA	n/a
EBIT	-219.56M
Earnings Per Share (EPS)	-$1.98

Full Income Statement

Balance Sheet

The company has $756.53 million in cash and n/a in debt, giving a net cash position of $756.53 million or $8.77 per share.

Cash & Cash Equivalents	756.53M
Total Debt	n/a
Net Cash	756.53M
Net Cash Per Share	$8.77
Equity (Book Value)	715.24M
Book Value Per Share	7.15
Working Capital	719.10M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-169.25M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-169.25M
FCF Per Share	-$1.96

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.21%
Shareholder Yield	-36.21%
Earnings Yield	-2.11%
FCF Yield	-2.83%

Analyst Forecast

The average price target for SYRE is $85.08, which is 23.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$85.08
Price Target Difference	23.97%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:25.

Last Split Date	Sep 8, 2023
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1